Neurodevelopmental disorders such as ADHD, ASD and learning disabilities are the most common cause of consultation in Pediatric Neurology in all countries. While pharmacological treatment has been extensively studied, in some conditions like ADHD, the access to stimulant medications in many countries is very limited and with very selective options. In addition, the high cost of medications makes them of inaccessible for many populations around the world. In other conditions, like ASD and LD, the benefits of medications are more controversial. Non- pharmacological and alternative interventions have been used extensively around the world without clear evidence of the benefits that they can provide to patients and families. Some of these alternative interventions are more expensive and have side effects that are often not disclosed. Parents have strongly advocated for research to demonstrate the real impact of those interventions.
In this symposium we aim:
• To present an update on therapeutic alternatives, beyond pharmacological interventions, for treating neurodevelopmental disorders like ADHD, ASD and learning disabilities.
• To discuss the evidence base available about the benefits of those interventions.
• To present a clinical model for the care of neurodevelopmental disorders that can be adapted by practitioners, worldwide.
- Learn how to evaluate and recommend common non- pharmacological interventions and technology aids as part of the treatment of patients with neurodevelopmental disorders.
- Learn how to develop programs to provide comprehensive evaluation and treatment for patients with neurodevelopmental conditions that decrease the long-term impact on their mental and physical health as they grow up.
- Use of some common non- pharmacological interventions and alternative therapies in Neurodevelopment disorders, especially Autism.
- How to coordinate chronic and long-term care for patients with neurodevelopment disorders, especially ADHD.
Organizer: Maria Teresa Acosta, MD; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
Alternative Therapies and Non-Pharmacological Treatment in Autism: What Parents Would Like to Know
Víctor Ruggieri, MD; Hospital de Pediatría J. P. Garrahan, Buenos Aires – Argentina
Advances in the Use of Technology and Virtual Reality for the Diagnosis and Treatment of ASD and Other Neurodevelopmental Disorders
Fernando Mulas Delgado, MD, PhD; Instituto Valenciano de Neurología Pediátrica, Valencia, Spain
Why to Treat ADHD as a Chronic Medical Condition: Impact of a Health Care Model and Long-Term Outcomes Maria Teresa Acosta, MD; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
Treatment of Neurodevelopmental Disorders without Geographic Barriers Victor Alejandro Gaona, MD; Universidad Nacional de Asunción, Centro Médico La Costa, Asunción – Paraguay